For the year ending 2025-12-31, ANGI had -$112,844K decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net earnings (loss) attributable to continuing operations | 43,832 |
| Depreciation | 45,319 |
| Provision for credit losses | 48,491 |
| Stock-based compensation expense | 14,758 |
| Non-cash lease expense (including impairment of right-of-use assets) | 7,366 |
| Amortization of intangibles | 1,800 |
| Deferred income taxes | 13,166 |
| Other adjustments, net | 1,190 |
| Accounts receivable | 43,754 |
| Other assets | -13,391 |
| Accounts payable and other liabilities | -3,825 |
| Operating lease liabilities | -13,070 |
| Income taxes payable and receivable | -1,170 |
| Deferred revenue | -20,041 |
| Net cash provided by operating activities attributable to continuing operations | 105,073 |
| Capital expenditures | 59,600 |
| Purchases of marketable debt securities | 0 |
| Proceeds from maturities of marketable debt securities | 0 |
| Net proceeds from the sale of a business | 0 |
| Proceeds from sales of fixed assets | 145 |
| Net cash used in investing activities attributable to continuing operations | -59,455 |
| Debt issuance costs | 1,684 |
| Purchases of treasury stock | 148,676 |
| Purchase of noncontrolling interests | 0 |
| Withholding taxes paid on behalf of employees on net settled stock-based awards | 7,982 |
| Distribution from iac pursuant to the tax sharing agreement | 0 |
| Other, net | 0 |
| Net cash used in financing activities attributable to continuing operations | -158,342 |
| Total cash (used in) provided by continuing operations | -112,724 |
| Net cash provided by operating activities attributable to discontinued operations | 0 |
| Net cash provided by investing activities attributable to discontinued operations | 0 |
| Total cash provided by discontinued operations | 0 |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | -120 |
| Net (decrease) increase in cash and cash equivalents and restricted cash | -112,844 |
| Cash and cash equivalents and restricted cash at beginning of period | 416,545 |
| Cash and cash equivalents and restricted cash at end of period | 303,701 |
Angi Inc. (ANGI)
Angi Inc. (ANGI)